)
Arctic Bioscience (ABS) investor relations material
Arctic Bioscience Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Statistically significant anti-inflammatory effects of HRO350 were demonstrated in the HeROPA/Europa studies, with improved skin symptoms and quality of life in psoriasis and confirmation of benefits in the per-protocol population.
Clinical glaucoma studies confirmed neuroprotective potential and vision improvement with ROMEGAⓇ herring caviar oil, with plans for larger trials and ongoing partner discussions.
Strong Nutra sales rebound in the Americas, with new customers and leads driving growth, and further expansion expected through 2026.
Operational focus on cost reduction, with OPEX down by NOK 8.9 million year-over-year and minimal CAPEX in pharma following study completions.
NOK 2.5 million grant awarded for oral aquaculture vaccine development, and Arctic Orphan (ABS302) project reached a key product formulation milestone.
Financial highlights
Q3 2025 sales revenues were NOK 8.7 million, down from NOK 11.1 million in Q3 2024, with Nutra revenues slightly down year-over-year due to recall impacts.
Gross margin for Q3 2025 was 21.6%, down from 31.8%/33.5% in Q3 2024, impacted by recall-related costs and a NOK 2.3 million provision in 2024.
EBITDA for YTD Q3 2025 was NOK -21.4 million, improved from NOK -31.0 million in 2024.
Available liquidity at quarter-end was NOK 7.0–7.5 million, with ongoing focus on cost control and income growth.
American market revenue grew by over NOK 6 million year-over-year, surpassing 2024's total.
Outlook and guidance
Anticipates strong year-end and further growth in Americas and B2B channels, with recurring business from new customers and B2C expansion in Northern Europe and Asia pending regulatory approvals.
Strategic partnerships and regulatory engagement for HeROPA/HRO350 development are being pursued, with further development to be funded through partnerships or project-specific funding.
Liquidity situation is closely monitored, with ongoing board assessment and positive bank dialogue.
Significant upside potential in cost supplement business expected in 2026.
Next Arctic Bioscience earnings date
Next Arctic Bioscience earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)